Pelvic mesh is a medical device originally designed for hernia repair that was repurposed for use in women suffering from conditions including pelvic organ prolapse (POP) and stress urinary incontinence (SUI). However, the device was not tested by the FDA for this use. Thousands of injured women allege that the mesh erodes prematurely, causing injuries including severe pain, sexual dysfunction and gynecological problems. The FDA has received an extraordinary number of complaints regarding transvaginal mesh devices. Two recent verdicts against manufacturers Ethicon and Boston Scientific have been announced this month. Click on the link below for details of each case

Jury hits Ethicon with $3.25 mln verdict in mesh case (Reuters)